Physician profile
Maureen Storey
NPI 1295759900
$1,363.73
in general payments reported to CMS, 2019-2025
10 companies · $24.14 in 2025
The $24.14 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $336 · 2022: $222 · 2023: $545 · 2024: $236 · 2025: $24.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $739.55 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $823.86 | 2021-2024 | Biktarvy, Descovy |
| Janssen Products, LP | $184.95 | 2021-2022 | |
| Zimvie INC. | $127.15 | 2023 | |
| Astellas Pharma US INC | $78.69 | 2023-2024 | Myrbetriq |
| Janssen Biotech, INC. | $49.73 | 2021-2023 | Symtuza |
| Orthofix Medical, INC. | $27.16 | 2023 | Physio-Stim |
| Abbott Laboratories | $24.14 | 2025 | Freestyle Libre 3 |
| Boston Scientific Corporation | $18.48 | 2021 | |
| Glaxosmithkline, LLC. | $16.71 | 2022 | |
| Dynasplint Systems INC. | $12.86 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Storey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.